Zydus Lifesciences Limited has informed the Exchange about General Updates
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences' indirect wholly-owned subsidiary, Amplitude SAS, has completed the acquisition of 100% share capital of FBC Medical, France for Euro 700,000 in cash. FBC Medical is a sales agent specializing in medical equipment distribution in four French departments (35, 22, 29, 56), with FY2025 turnover of Euro 935,000 and a paid-up capital of Euro 5,000. The target entity was incorporated in 2016. The acquisition is intended to internalize commercial capabilities currently outsourced to third-party sales agents, eliminating ongoing commission and business development fees to reduce long-term selling and distribution costs. The transaction is not a related party transaction.
The acquisition strengthens Zydus Lifesciences' European commercial operations by bringing sales capabilities in-house, potentially improving margins on medical equipment distribution in France. The deal size is modest (Euro 700,000) relative to the company's scale.